Guest Opinion: Oregonians deserve help from Congress to preserve access to pharmaceuticals

Guest Opinion: Oregonians deserve help from Congress to preserve access to pharmaceuticals Last week, we learned that Merck’s five-day course of [molnupiravir](/story/news/2021/10/01/new-antiviral-drug-molnupiravir-prevented-half-severe-covid-19-infections-study-found/5938807001/) for COVID-19 cut the risk of hospitalization of the clinical trial participants with moderate or mild symptoms in half.

Read the source article at Home
2021-10-08 19:01:22